Navidea Biopharmaceuticals EBITDA 2010-2023 | NAVB

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Navidea Biopharmaceuticals ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Navidea Biopharmaceuticals ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$180.6B
Intuitive Surgical (ISRG)	$177.8B
Edwards Lifesciences (EW)	$46.9B
IDEXX Laboratories (IDXX)	$45.5B
Alcon (ALC)	$45.3B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$33.9B
Mettler-Toledo (MTD)	$26.3B
STERIS (STE)	$22.7B
Waters (WAT)	$18B
SONOVA HOLDING (SONVY)	$17.5B
Hologic (HOLX)	$14.8B
Sysmex ADR (SSMXY)	$10.7B
Penumbra (PEN)	$9B
Masimo (MASI)	$8.9B
Globus Medical (GMED)	$7.4B
Glaukos (GKOS)	$5.4B
Teleflex (TFX)	$5.2B
Integer Holdings (ITGR)	$3.8B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.1B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2.1B
Elekta AB (EKTAY)	$2B
Veracyte (VCYT)	$2B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Tandem Diabetes Care (TNDM)	$1.1B